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The ACTH test has been used to confirm the diagnosis of adrenal insufficiency and the classic and the non-classic adrenal hyperpla-
sia due to the 3-HSD, 21 OH e 11OH deficiencies. This article reviews the historical aspects of the use of ACTH in the diagnosis of
hirsutism and points out its mains indications. In spite of new biological molecular advances in the diagnosis of adrenal enzymatic
deficiencies, the use of the ACTH test can help the physician to predict both genothipus and fenothipus in populations with
hyperandrogenic manifestations due to non-c1assical or late-onset congenital adrenal hyperplasia.
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INTRODUCTION
Historical aspects
S ince the introduction of the test involving infusionof pituitary adrenocorticotropin hormone (ACTH)in 1948, I clinicians and gynecologists in general
have been using the method to evaluate adrenal function
in patients suspected of having adrenal insufficiency or
congenital adrenal hyperplasia.
As far as the gynecological aspects are concerned,
clinicians must be alert to the interpretation of the test;
recent publications point out that patients with congenital
adrenal hyperplasia in its late-onset or non-classical form
lnay present a clinicaI picture consisting of irregular
menses, hirsutism and other hyperandrogenic
lnanifestations.
ACTH is a physiological agent that stimulates the
biosynthesis of the adrenal cortex layers and is directly
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stimulated by the corticotropin releasing factor (CRF) of
hypothalalnic origino Thus, the adrenal cortex is evaluated
clinically on the basis of its response to ACTI-I
administration.
At first the test was used only for patient~ with adrenal
insufficiency2 and was considered to be costly and highly
complexo With the advent of cosyntropin, a synthetic
ACTH derivative that reduced alIergic phenomena, the
test. started to be used to diagnose late-onset synthesis
deficiencies, i .e., the non-classical cases suspected of
congenital adrenal hyperplasia.
Most reports unanimously state that after ACTH
stimulation, there is an important increase of almast alI
androgen precursors; for this reason, the test may identify
patients with late-onset 21-0H (21-hydroxilasis) and 11-
OH deficiency (11-hydroxilasis), as welI as 3-HSD (3-
hydroxysteroid dehydrogenasis) deficiency.3
Thus, the test started to be employed more frequently
in the late 1960s, with different doses and routes being
used.4.5 Today, the test is performed by intravenous infusion
of 0.25 mg ACTHI.2, folIowed by blood collection 30 to
60 minutes Iater. The test can determine with precision
the glandular adrenal reserve for each hormone separately.
By studying the relationships between the hormones and
their respecti ve precursors, it is possible to determine
diagnostic patterns for the deficiency of enzy.mes possibly
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involved in the etiology of hyperandrogenism, especially
3-hydroxysteroid dehydrogenase (3-HSD, 21-hydroxylase
(21-0H) and ll-hydroxylase (ll-OH).ó
Despite the established use of the test, the literature
is not unanimous about its indication. CHETKOWISKI et
aI., after evaluating patients with late-onset 21-0H
deficiency, concluded that the ACTH test does not
precisely identify these patients, in addition to being
excessively costly.7
DIAGNOSTIC OF THE ENZIMATIC
DEFICIENCIES
In the detection of late-onset 21-0H deficiency,
measuring 17-0H-progesterone after stimulus provides an
important source of additional information.xThe diagnosis
of this deficiency is based on the evaluation of plasma 17-
OH-progesterone leveIs; however, the literature has
reported different interpretations of the testo
AZZIZ & ZACUR consider women to be carriers
when their 17-0H-progesterone leveIs exceed 1200 ng/dl
after intravenous ACTH infusion.x In contrast,
DEWAILLY et aI. suggested that patients with 170H-
progesterone leveIs exceeding SOO ng/dl which are reduced
by dexamethasone should not be submitted to the ACTH
stimulation test as they would be considered to have non-
classical21-0H deficiency. When these values are between
200 and SOO ng/dl, the patient would be considered
borderline and should be submitted to the testo Those with
leveIs of less than 200 ng/dl would not be considered to
have late-onset 21-0H deficiencyY
In the Endocrine Gynecology Sector of the
Department of Gynecology, Escola Paulista de Medicina,
Federal Unjversity of São Paulo, we use the NEW
nomogram to evaluate these patients. With respect to 11-
OH deficiency, which is much lnore rare, measurement of
compound S basely and after ACTH is also helpful for
diagnosis. There are no clear criteria to identify these
patients.
To evaluate 3-HSD activity, the diagnostic criteria
most frequently employed were those proposed by PANG
et aI., i.e.: 1. post-stimulus 17-0H-pregnenolone leveIs two
standard deviations above the leveIs detected in normal
women (S 170H-P>1639 ng/dl OI'49.2 nmol/I); 2. post-
stimulus DHEA leveIs two standard deviations above the
leveIs observed in normal women (DHEA> 1818 ng/dl 01'
63.1 nmoll1); 3. 170H-pregnenolone/170H-progesterone
ratio two standard deviations above the values detected in
normal women C170H-progesterone>6.4); and 4. 170H-
pregnenolone/cortisol ratio two standard deviations above
normal values (170H-pregnenolone/cortisol>S2).'o
Although these diagnostic criteria are widely
accepted, they are not unanilnously endorsed. GIBSON
et aI. used pregnenolone measurements,11 whereas LOBO
& GOEBELSMAN used a standardized DHEA-S
Ineasurelnent as a criterion.12 Other authors have
emphasized the DHEA/androstenedione ratio,5 whereas
REDMOND et aI. prefer the use of urinary Inetabolites.13
The tretacosatide depot (ACTH-depot) forms a
complex with zinc hydroxide when used in the
intramuscular form, with a slow and chronic .ACTH release
for a period of no less than 36 to 48 hours. Clinically, it is
used in situations in which it is desirable to increase seruln
cortisollevels. Like intravenous ACTH, it cau also be used
to diagnose adrenal synthesis deficiencies due to the more
potent and prolonged stimulus it provides for the three
adrenal layers, chronically depleting their production.
PRATA LIMA, in a study of the effect of ACTH on
nonnal WOlnen and women with idiopathic hirsutisln,
suggested criteria for the diagnosis of 3-HSD deficiency
after detecting a considerable increase in the hormones of
the fasciculated Iayer and a significant elevation of
. peripheral androgens such as S-DHEA and testosterone,
a fact that is not observed when intravenous ACTH is
used.14
CONCLUSIONS
Today, some reports tend to disregard the ACTH testo
There are two reasons behind this attitude. The first has to
do with the fact that 21-0H deficiency, by being linked to
the HLA system, would not require the test but simply an
anaIysis ofthese histocompatibility antigens. However, the
cost of, and difficuIt access to this procedure are not taken
into consideration. BARNES et aI. stated that the excessive
number of patients with 3-HSD deficiency reported over
the last few years should be considered with some caution
since there may be other changes in steroid Inetabolism
that simulate this defect. 15However, the fact that an HLA-
Iinked antigen for the deficiency has not yet been identified
cannot ruIe out the testo
Thus, the test using ACTH stimuIation by the
conventional method OI'use of the ACTH-depot may be
of heIp in the reproductive and endocrine function of
wOlnen in general with lnenstrual and aesthetic
repercussions.
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